Royal Philips has launched a non-invasive ventilator, BiPAP A40 EFL, to remotely monitor patients with chronic obstructive pulmonary disease (COPD) and help them to breathe easier. The device is already available in some European countries, and its expansion to the rest of Europe is expected in the next…
News
A study has found that fast response to noninvasive ventilation (NIV) following acute exacerbation in people with chronic obstructive pulmonary disease (COPD) is associated with NIV success and significantly lower in-hospital mortality. Identified risk factors for…
Health Care Service Corporation (HCSC) has issued a positive coverage policy for Pulmonx’s Zephyr Endobronchial Valve for treating severe emphysema, a form of chronic obstructive pulmonary disease (COPD). HCSC is the largest customer-owned health insurer in the U.S., and the fifth largest insurer…
The U.S. Food and Drug Administration has granted clearance to PulmoScan, a device developed by Cognita Labs that will facilitate at-home testing of lung function. The device could be useful in providing care to people with respiratory conditions such as asthma and chronic obstructive pulmonary disease…
Training in the handling of inhaler devices improved treatment and eased clinical symptoms in older people with chronic obstructive pulmonary disease (COPD), a study found. COPD patients with evidence of cognitive decline also benefitted from the eight-day training course. The study, “Training improves the handling of inhaler devices…
The first participant has been treated in a clinical trial testing CSA Medical’s RejuvenAir System as a potential treatment for people with moderate to severe chronic obstructive pulmonary disease (COPD) with chronic bronchitis. The participant was treated at Temple University Hospital. At present, the multicenter international…
A committee from the European Medicines Agency (EMA) recommended that AstraZeneca‘s triple combination therapy Trixeo Aerosphere (formoterol fumarate/glycopyrronium bromide/budesonide) be approved as a maintenance treatment for chronic obstructive pulmonary disease (COPD). The recommendation, from the EMA’s Committee for Medicinal Products for…
Exposure to cigarette smoke during pregnancy impairs lung embryonic development, which may increase the baby’s later-in-life risk for disorders like chronic obstructive pulmonary disease (COPD), a mouse study suggests. Smoke was found to increase the levels of the amphiregulin (AREG) protein, which may impair the formation of certain…
The use of face masks does not cause intoxication induced by exhaled carbon dioxide (CO2), even in people with lung function impairment such as those with chronic obstructive pulmonary disease (COPD), a study reports. The study, “Effect of Face Masks on Gas Exchange in Healthy Persons and Patients…
Older patients with chronic obstructive pulmonary disease (COPD) taking oral, synthetically-made cannabinoids — medications based on compounds found naturally in marijuana (the plant Cannabis sativa) — to manage some of their symptoms have a 64% higher risk of death compared to those not taking the medications, according to…
Recent Posts
- The value of tapping into COPD community resources
- Tozorakimab reduces COPD exacerbations in two large clinical trials
- Losing myself, finding myself: How recovery is harder with COPD
- Redrawing the geography of my life one breath at a time
- A diagnosis is a map that shows our way through an unknown land